Preclinical Studies and Drug Combination of Low-Cost Molecules for Chagas Disease

Preclinical Studies and Drug Combination of Low-Cost Molecules for Chagas Disease

Chagas disease is caused by the protozoan <i>Trypanosoma cruzi</i> (<i>T. cruzi</i>). It remains the major parasitic disease in Latin America and is spreading worldwide, affecting over 10 million people. Hundreds of new compounds with trypanosomicidal action have been identif...

Full description

Bibliographic Details
Main Authors: Elena Aguilera, Carina Sánchez, María Eugenia Cruces, Belén Dávila, Lucía Minini, Florencia Mosquillo, Leticia Pérez-Díaz, Elva Serna, Susana Torres, Alicia Schini, Luis Sanabria, Ninfa I. Vera de Bilbao, Gloria Yaluff, Flavio R. Zolessi, Luis Fabian Ceilas, Hugo Cerecetto, Guzmán Alvarez
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Pharmaceuticals
Subjects:
Chagas disease
pre-clinically studied
drug combination
RMN metabolomics
Online Access:https://www.mdpi.com/1424-8247/16/1/20

Internet

https://www.mdpi.com/1424-8247/16/1/20

Similar Items